Wells Fargo & Company Ginkgo Bioworks Holdings, Inc. Transaction History
Wells Fargo & Company
- $407 Billion
- Q2 2024
A detailed history of Wells Fargo & Company transactions in Ginkgo Bioworks Holdings, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 50,947 shares of DNA stock, worth $287,850. This represents 0.0% of its overall portfolio holdings.
Number of Shares
50,947
Previous 81,946
37.83%
Holding current value
$287,850
Previous $95,000
83.16%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding DNA
# of Institutions
347Shares Held
925MCall Options Held
1.04MPut Options Held
2.23M-
Viking Global Investors LP143MShares$808 Million0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA139MShares$785 Million0.0% of portfolio
-
Baillie Gifford & CO134MShares$760 Million0.04% of portfolio
-
Anchorage Capital Group, L.L.C. New York, NY69.9MShares$395 Million7.28% of portfolio
-
Black Rock Inc. New York, NY42MShares$237 Million0.0% of portfolio
About Ginkgo Bioworks Holdings, Inc.
- Ticker DNA
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 1,287,779,968
- Market Cap $7.28B
- Description
- Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...